The possible relation of the cause and effect between pleural effusion and hypoplastic lung, however, remained unclear. The influence of pleural effusion on pulmonary growth in affected fetuses had to be clarified in order to establish proper perinatal management.
In the present study, we attempted to assess the correlation between lung weight and the time of initial diagnosis or the duration of presence of pleural effusion, in order to clarify the influence of pleural effusion on pulmonary growth in the human fetus.
Materials and methods
Thirty-three fetuses with pleural effusion were diagnosed antenatally, at the Maternity Care Unit of Kyushu University Hospital between January 1983 and March 1988. In 20 out of 33 cases, autopsies were performed and lung weights were measured, the results of which make up this study. Of the remaining 13 cases, 9 were excluded because of the family's refusal to allow an autopsy and the last 4 cases diagnosed after 30 weeks of gestation survived through to the time of this writing. Drainage of pleural effusion, on a continuous basis, from the thoracic cage in utero, was not performed on any of these cases.
Wet weight measured at autopsy was used as the weight for each organ. In order to evaluate pulmonary growth, the lung weight/body weight ratio and the standard deviation from the mean normal weight at each gestational age was used [5, 7] . The normal standard of body and organ weights used was that reported by GRUENWALD et al [3] . Information concerning the time of initial diagnosis and delivery, along with the findings at autopsy, were obtained from medical records kept in our hospital.
Statistical analysis was performed using the chisquare test, and a p-value of less than 0.05 was regarded as being statistically significant.
Results
Underlying diseases and lung weights of the twenty cases studied are shown in table I.
Gestational age at the time of initial diagnosis ranged from 21 to 35 weeks, and the time of delivery ranged from 23 to 36 weeks of gestation. The time between the initial diagnosis and delivery ranged in duration from 5 days to 8 weeks.
Lung weights ranged from 1.8 to 33.0 grams, and the lung weight/body weight ratio was less than 0.020 [5, 7] in all cases. The distribution of the standard deviation from the mean weight for the body, heart, liver and lungs is shown in figure 1 . Body weights were within the mean ± 1.5 S. D. in 11 of 20 cases, more than +1.5 S.D. in eight cases and less than -1.5 S. D. in one case. Heart weights were within the mean + 1.5 S. D. in 16 of 20 cases, more than + 1.5 S.D. in two cases and less than -1.5 S.D. in two cases. Liver weights were within the mean + 1.5 S. D. in 17 of 20 cases and less than -1.5 S.D. in three cases. Lung weights were within the mean ± 1.5 S. D. in eight of 20 cases, and less than -1.5 S.D. in 12 cases. The rate of incidence of cases with weights less than -1.5 S.D. in body, heart, liver and lungs is 5.0%, 10.0%, 15.0% and 60.0%, respectively. The incidence of cases with lung weights less than -1.5 S. D. was significantly higher than the incidence of cases with weights of less than -1.5 S. D. for other organs in cases with pleural effusion (p < 0.01). The correlation between the time of initial diagnosis and lung weight is shown in figure 2 . In all the cases with lung weights of less than -2.0 S. D., pleural effusion was diagnosed during the first 29 weeks of gestation. However, when the incidence of lung weights of less than -1.5 S.D. or -2.0 S. D. was compared by gestational age from 22 to 34 weeks, there were no statistical significant differences.
With regard to the correlation between the duration of the presence of pleural effusion and lung weight, the shortest duration showing a statistically significant difference obtained in the incidence of lung weights of less than -1.5 S. D. or -2.0 S.D., was two weeks. In six cases with a duration of less than two weeks, lung weights were within the mean ±1.5 S.D. On the contrary, in 14 cases having a duration of more than two weeks, lung weights were less than -1.5 S.D. in 12 cases (85.7%), and less than -2.0 S. D. in seven cases (50.0%) (figure 3). The incidence of cases with lung weights of less than -1.5 S.D. or -2.0 S.D. significantly increased in situations where the duration of pleural effusion was more than two weeks, compared to those cases in which the duration was less than two weeks (p < 0.01, p < 0.05, respectively). Weight + 2.0SD Γ + 1.5SD
Discussion
Pleural effusion in a fetus, theoretically, can inhibit pulmonary growth by increasing intrathoracic pressure. However, the relation of cause and effect between persistent pleural effusion and the development of hypoplastic lung has not been proven in human subjects.
CASTILLO et al [1] , and SHIMOKAWA et al [9] reported that the outcome of nonimmunologic hydrops fetalis (NIHF) with pleural effusion is significantly poor, compared to that of NIHF without pleural effusion, and suggested that the cause of death may be associated with the coexistence of hypoplastic lung. CASTILLO et al [2] reported that normal lung development was disturbed in 9 cases of NIHF with pleural effusion, using histological examination. In the present study, 12 of 20 cases had lung weights of less than -1.5 S. D. and 7 cases had lung weights of less than -2.0 S.D. This evidence indicates that persistent pleural effusion often coexists with the inhibition of pulmonary growth in the fetus, irrespective of underlying diseases the fetus may have.
With regard to the definition of hypoplastic lung, REALE et al [7] proposed a lung weight/body weight ratio of less than 0.020 as an indicator. NIMROD et al [5] proposed both a lung weight/ body weight ratio of less than 0.020 and a lung weight of less than -2.0 S.D. as the indicator of hypoplastic lung. For evaluating the hypoplastic lung in NIHF, the criteria of NIMROD et al [5] seems to be better than that of REALE et al [7] , because body weight in NIHF may be heavy due to the accumulation of ascites or pleural effusion. In the present study, the lung weight/body weight ratio was less than 0.020 in all cases, but lung weights of less than -2.0 S. D. were found in only seven of 20 cases. These results indicate that a fetus with pleural effusion does not always have hypoplastic lung. In this study, all seven cases with hypoplastic lung as defined by the criteria of NIM-ROD et al [5] had a duration of persistent pleural effusion of more than two weeks. On the contrary, in the six cases, with a duration of less than two weeks, lung weights were within the mean ±1.5 S.D. This fact suggests that pulmonary growth may not be inhibited if the duration of persistent pleural effusion is less than two weeks, and indicates that the development of pulmonary hypoplasia in a fetus with pleural effusion depends on the duration of the pleural effusion.
In addition, the time of onset of pleural effusion may also influences pulmonary growth in the fetus. The structural development of the human fetal lung has been divided into the following four stages [4] ; 1) the embryonic stage, 2) the pseudoglandular stage, 3) the canalicular stage and 4) the alveolar stage. The earlier the gestational age at the onset of pleural effusion, the stronger the influence on pulmonary development may be. CASTILLO et al [2] suggested that significant fluid ; accumulation in the pleural space prior to the alveolar stage could cause inevitable damage to the developing lung in a fetus. NIMROD et al [6] reported that, in fetuses with premature rupture of membrane, the risk of developing pulmonary hypoplasia was significantly higher in fetuses with rupture of membranes before 26 weeks of gestation, compared to that of fetuses with a rupture of membrane after 26 weeks of gestation. Although, in the present study, the time of onset of pleural effusion could not be diagnosed accurately, the time of diagnosis was before 29 weeks of gestation in all the cases with lung weights of less than -2.0 S.D. With regard to the relation between time of diagnosis and lung weight, however, there was no statistical significant difference in the incidence of lung weights of less than -1.5 S. D. or -2.0 S.D. among the gestational age groups divided by one-week intervals, ranging from 22 to 34 weeks. Further investigation is necessary to clarify the correlation between the time of onset of pleural effusion and the development of pulmonary hypoplasia.
In conclusion, the findings indicate that persistent pleural effusion in a fetus can inhibit pulmonary growth, and that the development of hypoplastic lung in fetuses with pleural effusion depends on the length of the presence of pleural effusion. In addition, the results also suggest that pulmonary growth may not be influenced by persistent pleural effusion of less than two weeks. Therefore, pulmonary hypoplasia in a fetus with pleural effusion may be prevented by continuous removal of pleural effusion using an effective drain in utero.
Abstract
The present study was performed to clarify the relation of cause and effect between pleural effusion and hypoplastic lung in the human fetus. In six cases with a duration of less than two weeks between the initial diagnosis of pleural effusion and delivery, lung weights were within the mean weight ± 1.5 S.D. In fourteen cases with a duration of more than two weeks between diagnosis and delivery, seven cases had lungs with weights of less than -2.0 S. D. and twelve had lungs of Keywords: Fetus, hypoplastic lung, pleural effusion.
less than -1.5 S.D. in weight. The incidence of lung weights less than -1.5 S.D. or -2.0 S.D. was significantly higher in cases with a diagnosis-delivery duration of more than two weeks, compared to those with a duration of less than two weeks. These results suggest that the development of hypoplastic lung in fetuses with pleural effusion may depend on the length of the presence of pleural effusion.
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